Dr. Agarwal's Health Care Quarterly Results

Latest Quarter Net Profit
₹57 Cr
QSept 2026
Quarterly Results

Dr. Agarwal's Health Care quarterly results. In Sept 2026, Dr. Agarwal's Health Care (AGARWALEYE) reported revenue ₹665 Cr and net profit ₹57 Cr — revenue +31.2% YoY. For annual financials, live price and key ratios, visit Dr. Agarwal's Health Care share price chart.

AGARWALEYE Quarterly Results — Revenue, Profit & EPS Highlights

Dr. Agarwal's Health Care latest quarter revenue, net profit, EPS and QoQ/YoY growth rates. Also explore AGARWALEYE share price history to track price trends across different timeframes.

  • Revenue of ₹665 Cr in Sept 2026 (+15.1% vs Mar 2026, +31.2% vs Sept 2025)
  • Net Profit of ₹57 Cr in Sept 2026 (+14.0% vs Mar 2026, +54.1% vs Sept 2025)
  • EBITDA of ₹186 Cr in Sept 2026 (+6.3% vs Mar 2026)
  • Operating Margin of 27.0% in Sept 2026 (-2.0pp vs Mar 2026)
  • Earnings Per Share of ₹1.65 in Sept 2026 (+32.0% vs Mar 2026)

Dr. Agarwal's Health Care Quarterly Results — Revenue, EBITDA, Net Profit & EPS

AGARWALEYE quarterly revenue, expenses, EBITDA, net profit, EPS and operating margin with QoQ and YoY comparison.

Metric Sept 2026 Mar 2026 Jun 2026 Sept 2025 Mar 2025 QoQ YoY
Revenue (₹ Cr) 665 578 620 507 476 15.1% 31.2%
Net Profit (₹ Cr) 57 50 55 37 43 - -
EBITDA (₹ Cr) 186 175 177 144 144 - -
EPS (₹) 1.65 1.25 1.55 1.07 1.04 - -
Operating Margin (%) 27.0% 29.0% 28.0% 27.0% 28.0% - -

AGARWALEYE Share Price Trend — 1-Year Movement Across Quarterly Results

Dr. Agarwal's Health Care 1-year share price in ₹ overlaid with quarterly earnings dates — NSE/BSE closing prices. View AGARWALEYE 52-week chart for the annual high/low range and current price position.

Profitability Ratios

Profit Margin 8.6%
EBITDA Margin 28.0%
Operating Margin 27.0%
ROE (Annual) 10.8%

Balance Sheet Highlights

Total Assets ₹3,942 Cr
Total Equity ₹2,120 Cr
Current Assets ₹ Cr
Current Liabilities ₹1,361 Cr

Cash Flow Analysis

Operating Cash Flow ₹519 Cr
Investing Cash Flow ₹-309 Cr
Financing Cash Flow ₹-220 Cr
Net Cash Flow ₹-10 Cr

Current Market Data

Current Price ₹553.10
Exchange NSE
Last Updated Nov 19, 2026

AGARWALEYE vs Healthcare Peers — Quarterly Revenue, Profit & Market Cap

Dr. Agarwal's Health Care latest quarter revenue and net profit vs Healthcare competitors — market cap, price and earnings comparison.

Company Latest Quarter Market Cap (₹ Cr) Price (₹) Revenue (₹ Cr) Net Profit (₹ Cr) Rev QoQ % Rev YoY % Profit Margin % P/E Ratio
Sun Pharmaceutical
Sept 2026
₹451,074.97 Cr 1900.0 16,617 1,995 +10.6% - 12.0% 228.9
Divis Laboratories
Sept 2026
₹294,139.19 Cr 11178.0 3,770 1,127 +26.3% - 29.9% 263.1
Torrent Pharmaceuti…
Mar 2026
₹188,719.51 Cr 4611.0 4,111 364 +27.7% +42.2% 8.9% 400.6
Apollo Hospitals
Sept 2026
₹126,832.45 Cr 8738.0 7,673 660 +15.2% - 8.6% 199.4
Laurus Labs
Sept 2026
₹125,946.78 Cr 2306.0 2,219 436 +21.7% - 19.6% 282.3
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data

QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores